Ambulatory Infusion Centers Market Revenue to Attain USD 126.27 Bn by 2033


08 Jul 2025

Share : linkedin twitter facebook

The global ambulatory infusion centers market revenue reached USD 50.63 billion in 2025 and is predicted to attain around USD 126.27 billion by 2033 with a CAGR of 10.69%. The market is growing due to the increasing demand for cost-effective, patient-centered outpatient care for chronic and complex conditions, which require long-term infusion therapies.

Ambulatory Infusion Centers Market Revenue Statistics

Market Overview

The ambulatory infusion centers market is experiencing robust growth, primarily due to the increasing prevalence of chronic diseases like cancer, autoimmune diseases, and neurological conditions. Another major factor driving the growth of the market is the trend toward outpatient care for its convenience and cost reduction. Advances in infusion pumps and drug delivery technology are enhancing the patient’s safety and therapy efficacy, making infusion centers a more attractive alternative to hospitals. The rapid shift toward outpatient care due to the increased costs of hospital treatments opens up new growth avenues. Moreover, supportive reimbursement policies from insurance providers encourage the use of ambulatory infusion centers.

Segment Insights

  • By therapy type, the biological therapy segment held the largest revenue share of the market in 2024. This is mainly due to the increased demand for biologics in the treatment of autoimmune disorders. Advances in drug delivery systems are enhancing the efficacy of these therapies, contributing to segmental growth.
  • By application, the autoimmune disorders segment led the market with a major share in 2024. This is due to the increased prevalence of autoimmune disorders worldwide, boosting the need for targeted or infusion-based therapies.
  • By end-user, the standalone/independent Infusion centers segment held the largest share of the market in 2024. These centers are gaining popularity as an alternative to traditional health systems, focusing on optimized patient experiences and streamlined patient care pathways. Shorter waiting times in these centers enhance overall patient outcomes.
  • By payor type, the commercial insurance segment continues to dominate the market. The increasing focus on employee well-being is a major factor supporting segmental growth. Many insurance companies are expanding their product portfolio by adding flexible insurance coverage for employees.

Regional Insights

North America held the largest revenue share of the ambulatory infusion centers market in 2024. This is due to its well-developed healthcare system, viable reimbursement structures, and a heightened demand for outpatient therapies. The rapid expansion of ambulatory care centers and the growing focus on patient-centric care contribute to regional market growth.

Asia Pacific is the fastest-growing region in the market. The growth of the market within the region is attributed to the rising prevalence of chronic disease, escalating healthcare spending, and the increasing access to outpatient infusion care. Moreover, there is a rapid shift toward outpatient care to reduce unnecessary hospital visits and hospital admissions, which further supports market growth.

Ambulatory Infusion Centers Market Coverage

Report Attribute Key Statistics
Market Revenue in 2025 USD 50.63 Billion
Market Revenue by 2033 USD 126.27 Billion
CAGR from 2025 to 2033 10.69%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2024
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Recent Development

  • On June 25, 2025, a new ambulatory center opened at Johnson Memorial Hospital's campus in Enfield, offering outpatient care without having to go to a hospital. This center is equipped with advanced diagnostic imaging and outpatient surgical capabilities, boosting community-based service access.
    (Source: https://www.ctinsider.com)

Ambulatory Infusion Centers Market Key Players

  • Option Care Health
  • InfuCare Rx
  • Coram CVS (now part of Option Care)
  • KabaFusion
  • BioScrip (now part of Option Care)
  • Amerita (a PharMerica company)
  • United Infusion
  • Soleo Health
  • Paragon Healthcare
  • PromptCare
  • ContinuumRx
  • CareCentrix
  • Chartwell Pennsylvania
  • Intramed Plus
  • AlayaCare
  • ClearSky Health
  • Healix Infusion Therapy
  • Nufactor (a FFF Enterprises company)
  • PharMerica Infusion Services
  • Infusion Associates

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6352

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344

Related Reports